$131.820
+0.738 (+0.56%)Al cierre
Noticias de HWKN
Eventos de HWKN
Hawkins Completes Acquisition of Eagle Labs Assets
Hawkins has completed the acquisition of the assets of Eagle Labs. Eagle Labs distributes water treatment products directly to customers in Texas from its operations in the Dallas-Fort Worth region and has in-house manufacturing capabilities.
Hawkins Raises Quarterly Cash Dividend by 5% to 20 Cents
Hawkins raised its quarterly cash dividend by 5% to 20c per share from 19c, payable August 28 to shareholders of record on August 14.
Company Reports Q1 Revenue of $315.7 Million
Reports Q1 revenue $315.7M, consensus $313.42M. Executive Commentary - Patrick H. Hawkins, Chief Executive Officer and President: "Our first quarter was a solid start to the year, highlighted by another quarter of record results in revenue, gross profit, and adjusted EBITDA" said Patrick Hawkins, Chief Executive Officer and President. "Our record revenue of $315.7 million was the result of all three reporting segments growing year over year, and included organic revenue growth of approximately 5%, consistent with our expectation of returning to historical organic revenue growth rates in fiscal 2027."
CEO Outlook for Fiscal 2027 Revenue Growth
CEO Patrick Hawkins concluded, "Looking ahead to fiscal 2027, we are well positioned to grow revenue and operating income in each of our business segments and expect EPS to grow as well. We expect our balance sheet to remain strong, and with the diversity of our businesses and the overall strength of our company, we believe we will continue to generate strong operating cash flow. This will allow us to fund future growth investments and continue to pay down our debt during fiscal year 2027 as we expect to achieve a leverage ratio of approximately 1x adjusted EBITDA by the end of fiscal year 2027."
Company Achieves Over $1 Billion Revenue for Fiscal 2026
Reports Q4 revenue $265.9M, consensus $255.28M. Patrick H. Hawkins, CEO: "Fiscal 2026 was another milestone year for our company, as we crossed $1 billion in revenue, for the first time in our history. My thanks to every person connected to our great company for helping us accomplish this goal. This achievement resulted in a number of records for the year; including sales, gross margin, operating income, and adjusted EBITDA. Our focus has long been to deliver sustained growth over time, and we have continued to execute on that with pro forma EPS growth for the eighth consecutive year. Our disciplined M&A strategy remained a core competency for us and has again contributed to growth of Water Treatment, our largest reporting segment, which now represents 50% of our total company revenue and 56% of the total company operating income. We have completed 17 acquisitions over the last five years, most of which have helped to drive accelerated growth in our Water Treatment segment and we expect future acquisitions to continue to be focused on Water Treatment. With our latest deals, we now have a full product portfolio for our Water Treatment customers, including chemicals, media and filtration products, and equipment. Our Water Treatment segment achieved sales growth of 22% for the year, through sales from our acquired companies as well as organic growth. Sales in our Food and Health Sciences segment were relatively flat, mainly due to softness in the food and nutrition end markets, and our Industrial Solutions segment was up 6% for the year."
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.